Document is current
Any future updates will be listed below
-
Authors
Kalamo, Mari https://orcid.org/0000-0002-2983-1022
Mäenpää, Johanna
Seppälä, Toni
Mecklin, Jukka-Pekka
Pylvänäinen, Kirsi
Staff, Synnöve
-
Funding
Funding for this research was provided by:
Tampereen Yliopisto
Jane ja Aatos Erkon Säätiö
Pirkanmaan Rahasto
Naistentautien Tutkimussäätiö
Syöpäsäätiö
Pirkanmaan Sairaanhoitopiiri
- License Information
-
More Information
Article History
Received: 23 September 2020
Accepted: 17 August 2021
First Online: 14 September 2021
Declarations
:
: The study protocol was approved by TAUH Ethical Committee (4.1.2011/ Ref. ETL R10079) and an informed consent was obtained from all the study participants.
: All the study participants gave their informant consent to publish their personal data and comments collected by the questionnaire.
: Toni Seppälä is the CEO and co-owner of Healthfund Finland Oy (outside the submitted work), and reports a fee from Boehringer-Ingelheim (outside the submitted work). The other authors declare that they have no competing interests.
